ArticleHepatology international2025
Three-year overall survival in unresectable hepatocellular carcinoma treated with atezolizumab plus bevacizumab.
Masatsugu Ohara et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it